Compagnie Financière Richemont SA CFRUY OTC · Consumer cyclical · Switzerland
$20.51 -0.39% -$0.08
Summary
72 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 115% a year over the last 3 years.
- Out of every 100 EUR of revenue, 18 EUR is left as net profit.
- Analysts expect revenue to grow by 13% this fiscal year.
What to watch
- Revenue growth is slowing: 5.4% a year over the last 3 years against 11% over 5 years.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBy our assumptions the price matches the value of the business: the two differ by less than 10 %.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 25.7 EUR for 1 EUR of yearly profit. Over the last five years it was 79.5 EUR on average.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 5.4% a year. For the next fiscal year analysts expect revenue to grow by 13%. Earnings per share grew by 115% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 EUR of revenue goes
- Cost of sales 35 EUR
- Research and development 0.6 EUR
- Sales and administration 42 EUR
- Taxes and other 4.6 EUR
- Net profit 18 EUR
Net profit, industry median (Luxury Goods) 8.1 EUR
Out of every 100 EUR of revenue, 18 EUR is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.8 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 2.61%
- Paid out of profit
- 67%
- Raised in a row
- 1 year
You receive $0.54 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.